Literature DB >> 35997483

Trichodysplasia Spinulosa Polyomavirus Endothelial Infection, California, USA.

Lauren Lawrence, Aihui Wang, Gregory Charville, Angus Toland, Benjamin Pinsky, Yasodha Natkunam, Sheren Younes, Henning Stehr, Dita Gratzinger.   

Abstract

We describe 3 patients in California, USA, with trichodysplasia spinulosa polyomavirus (TSPyV) infection of endothelium after steroid administration. We detected TSPyV RNA in tissue specimens by in situ hybridization, which revealed localization to endothelial cells. These cases suggest that diseases associated with endothelial inflammation could be associated with TSPyV infection.

Entities:  

Keywords:  California; TSPyV; United States; alphapolyomavirus; endotheliitis; trichodysplasia spinulosa; trichodysplasia spinulosa polyomavirus; viruses

Mesh:

Year:  2022        PMID: 35997483      PMCID: PMC9423908          DOI: 10.3201/eid2809.220856

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   16.126


Trichodysplasia spinulosa polyomavirus (TSPyV) is an alphapolyomavirus whose primary clinical manifestation in a posttransplant setting is folliculocentric papular cutaneous eruptions, typically involving the face (). Identification of TSPyV nucleic acids in tonsillar tissue has led to the speculation that lymphoid tissue might be a latency site (); however, some disagreement exists in the literature as to whether the clinical diagnosis of trichodysplasia spinulosa reflects primary infection or reactivation of latent virus (,). Although cutaneous disease is the primary clinical manifestation of infection, TSPyV has been identified in blood, urine, cerebrospinal fluid, tonsils, and respiratory specimens by various methods, including nucleic acid detection, immunohistochemistry, and electron microscopy (,–). TSPyV DNA loads can be high, especially in blood (up to 108 viral copies/mL), months before the appearance of typical trichodysplasia spinulosa skin lesions (). This case study was part of a larger project approved by the Stanford Institutional Review Board (approval no. 58311) designed to explore oncogenesis by alphapolyomaviruses. We identified rare cases on our next generation sequencing panel of solid tumors with off-target, high quality reads that aligned to the TSPyV genome. We hypothesized that some of these cases might represent TSPyV-mediated neoplasms. Our cases comprised 1 patient with metastatic lung adenocarcinoma involving the brain (case 1), 1 patient with meningioma (case 2), and 1 patient with a metastatic perivascular epithelial cell tumor involving the liver (Table). It is unclear whether the mental status changes observed in cases 1 and 2 were attributable to viral infection or were secondary to the tumors (Table). All 3 patients received steroids immediately preceding resection. We performed in situ hybridization using a custom RNAScope probe that targeted the complete TSPyV viral genome (GenBank accession no. NC_014361.1) and RNAscope 2.5 HD Reagent Kit-RED (Advanced Cell Diagnostics, https://acdbio.com) to detect TSPyV RNA in cutaneous biopsy specimens. One case of cutaneous trichodysplasia spinulosa was used as a positive control for TSPyV RNA. We used the RNAscope 2.5 LS Probe-Hs-PPIB-sense probe (Advanced Cell Diagnostics), which is specific for peptidylprolyl isomerase B, to demonstrate the presence of intact RNA in the tissue sections. For negative in situ hybridization controls, we used tissue specimens from patients with Merkel cell polyomavirus-positive Merkel cell carcinoma and BK polyomavirus nephropathy and a T-cell lymphoma tissue microarray that included 1 case of Merkel cell polyomavirus-positive T-cell lymphoma.
Table

Case summaries of 3 patients with trichodysplasia spinulosa polyomavirus endothelial infection, California, USA*

Case no.Histopathologic diagnosisImmunosuppressionLocalization of RNAClinical manifestation
1Metastatic pulmonary adenocarcinomainvolving brainDexamethasone (4 mg) leading up to resection; rituximab/bendamustine treatment completed 18 mo before resection for follicular lymphomaEndotheliumGround level fall, confusion, forgetfulness, ambulatory instability
2Anaplastic meningiomaDexamethasone (2 mg × 10 d, then 1 mg × 2 d) leading up to resection EndotheliumConfusion, headaches, cheek numbness, ambulatory instability
3Metastatic perivascular epithelial cell tumor involving liverGemcitabine/docetaxel completed 1 mo before resection; prednisone (8 mg orally 2×/d) for 1 mo leading up to resectionEndotheliumAbdominal pain, fever, vomiting, hypoxia
In contrast to our hypothesis, we found that TSPyV RNA did not localize to neoplastic cells. However, TSPyV RNA localized to the endothelium in all 3 cases (Figure). The BK polyomavirus nephropathy sections showed weak, orange-red discoloration of tubular epithelium (Figure, panel L) that was distinguishable from the bright red, granular staining patterns for TSPyV RNA observed in the positive control and tissue specimens from the 3 patients. This discoloration was interpreted as negative for TSPyV RNA by board-certified pathologists who had experience evaluating RNAScope in situ hybridizations.
Figure

Tissue samples from 3 patients with trichodysplasia spinulosa polyomavirus endothelial infection, California, USA. We performed hematoxylin and eosin (H&E) staining and RNAScope in situ hybridization (ISH) to detect trichodysplasia spinulosa polyomavirus (TSPyV) in formalin-fixed, paraffin-embedded tissue specimens. Bright red, granular staining in endothelium indicates TSPyV RNA. A) Case 1, H&E staining, original magnification ×10; B) case 1, TSPyV ISH, original magnification ×10; C) case 1, TSPyV ISH, original magnification ×40; D) case 2, H&E staining, original magnification ×5; E) case 2, TSPyV ISH, original magnification ×10; F) case 2, TSPyV ISH, original magnification ×40; G) case 3, H&E staining, original magnification ×5; H) case 3, TSPyV ISH, original magnification ×10; I) case 3, TSPyV ISH, original magnification ×40; J) biopsy from patient with cutaneous trichodysplasia spinulosa (positive control), TSPyV ISH, original magnification ×10; K) cutaneous biopsy from patient with Merkel cell polyomavirus-positive Merkel cell carcinoma (negative control), TSPyV ISH, original magnification ×40; L) renal biopsy from patient with BK polyomavirus nephropathy (negative control), TSPyV ISH, original magnification ×60.

Tissue samples from 3 patients with trichodysplasia spinulosa polyomavirus endothelial infection, California, USA. We performed hematoxylin and eosin (H&E) staining and RNAScope in situ hybridization (ISH) to detect trichodysplasia spinulosa polyomavirus (TSPyV) in formalin-fixed, paraffin-embedded tissue specimens. Bright red, granular staining in endothelium indicates TSPyV RNA. A) Case 1, H&E staining, original magnification ×10; B) case 1, TSPyV ISH, original magnification ×10; C) case 1, TSPyV ISH, original magnification ×40; D) case 2, H&E staining, original magnification ×5; E) case 2, TSPyV ISH, original magnification ×10; F) case 2, TSPyV ISH, original magnification ×40; G) case 3, H&E staining, original magnification ×5; H) case 3, TSPyV ISH, original magnification ×10; I) case 3, TSPyV ISH, original magnification ×40; J) biopsy from patient with cutaneous trichodysplasia spinulosa (positive control), TSPyV ISH, original magnification ×10; K) cutaneous biopsy from patient with Merkel cell polyomavirus-positive Merkel cell carcinoma (negative control), TSPyV ISH, original magnification ×40; L) renal biopsy from patient with BK polyomavirus nephropathy (negative control), TSPyV ISH, original magnification ×60. TSPyV is a DNA virus, and detection of TSPyV RNA indicates active viral replication and infection. Our in situ hybridization results suggest that TSPyV can infect endothelial cells, likely within various tissues. These cases provide insight into a potential cellular reservoir for TSPyV infection. In addition, these data raise the possibility that other diseases associated with endothelial inflammation could be associated with TSPyV infection. Overall, this small case series improves our knowledge of the scope of human TSPyV infection.
  6 in total

Review 1.  Molecular insight into the viral biology and clinical features of trichodysplasia spinulosa.

Authors:  J H Wu; H P Nguyen; P L Rady; S K Tyring
Journal:  Br J Dermatol       Date:  2015-12-14       Impact factor: 9.302

2.  Primary trichodysplasia spinulosa polyomavirus infection in a kidney transplant child displaying virus-infected decoy cells in the urine.

Authors:  Cinzia Borgogna; Silvia Albertini; Elisa Zavattaro; Federica Veronese; Licia Peruzzi; Els van der Meijden; Mariet C W Feltkamp; Antonella Tosoni; Alessandro Volpe; Renzo Boldorini; Marisa Gariglio
Journal:  J Med Virol       Date:  2019-07-02       Impact factor: 2.327

3.  Detection of TS polyomavirus DNA in tonsillar tissues of children and adults: evidence for site of viral latency.

Authors:  Mohammadreza Sadeghi; Leena-Maija Aaltonen; Lea Hedman; Tingting Chen; Maria Söderlund-Venermo; Klaus Hedman
Journal:  J Clin Virol       Date:  2013-11-27       Impact factor: 3.168

4.  Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients.

Authors:  Els van der Meijden; Barbara Horváth; Marcel Nijland; Karin de Vries; Emo Ke Rácz; Gilles F Diercks; Annelies E de Weerd; Marian C Clahsen-van Groningen; Caroline S van der Blij-de Brouwer; Arnulfo J van der Zon; Aloys C M Kroes; Klaus Hedman; Jeroen J A van Kampen; Annelies Riezebos-Brilman; Mariet C W Feltkamp
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 5.  Recent developments in trichodysplasia spinulosa disease.

Authors:  Deepika Narayanan; Peter L Rady; Stephen K Tyring
Journal:  Transpl Infect Dis       Date:  2020-08-16       Impact factor: 2.228

6.  Human polyomaviruses in children undergoing transplantation, United States, 2008-2010.

Authors:  Erica A Siebrasse; Irma Bauer; Lori R Holtz; Binh-minh Le; Sherry Lassa-Claxton; Charles Canter; Paul Hmiel; Shalini Shenoy; Stuart Sweet; Yumirle Turmelle; Ross Shepherd; David Wang
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.